Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Leukemia|January 11, 2013
Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemiaS H Oram, J Thoms, J I Sive, et al.
Genome Research|March 1, 1996
Construction of a consistent YAC contig for human chromosome region 3p14.1W Bardenheuer, S Michaelis, A Lux, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2009
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinibM Montemurro, P Schöffski, P Reichardt, et al.
British Journal of Cancer|December 10, 1999
Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trialW Eberhardt, G Stamatis, M Stuschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2009
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancerG Capri, J Chang, S-C Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2012
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapyN Penel, G D Demetri, J Y Blay, et al.
Oncogene|March 21, 2000
The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanomaS Ren, M J Smith, I D Louro, et al.
Leukemia|February 6, 2016
GFI1 as a novel prognostic and therapeutic factor for AML/MDSJ M Hönes, L Botezatu, A Helness, et al.
Pageof 5